Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech Calendar: Key Dates for December
TheStreet.com
Monday, November 30, 2009 - 11:00am
tags:
Exelixis, Dyax, OSI Pharmaceuticals, Isis Pharmaceuticals, Somaxon, Gilead Sciences, Eli Lilly, Vion Pharmaceuticals, Roche, Immunogen, Auxilium, BioDelivery Sciences, Arena Pharmaceuticals, Vivus, Synta
BioMarin treatment gets special FDA status
Yahoo/AP
Monday, November 30, 2009 - 10:59am
tags:
FDA, Biomarin, orphan drugs
Drug stocks split; Theravance slides on FDA setback
Marketwatch
Monday, November 30, 2009 - 10:47am
tags:
FDA, Theravance, drug stocks
Great Opportunity for Incyte
Yahoo/Zacks.com
Monday, November 30, 2009 - 10:40am
tags:
Incyte, Novartis
AstraZeneca Moves Drug Production to China, Begging Safety Questions for FDA
BNET Pharma
Monday, November 30, 2009 - 10:37am
tags:
FDA, AstraZeneca, drug manufacturing, China, drug safety
Sequenom Stock Now the Plaything of Rumors
BNET Pharma
Monday, November 30, 2009 - 10:37am
tags:
Sequenom
Daiichi Sankyo's CEO: Soft-talking revolutionary
FT.com
Monday, November 30, 2009 - 10:35am
tags:
Pharma CEOs, Daiichi Sankyo, Takashi Shoda
Patent issued for Allos Therapeutics' cancer drug Folotyn
Bizjournals.com
Monday, November 30, 2009 - 10:33am
tags:
Allos, Folotyn, patents, lymphoma
Eli Lilly's Cymbalta gets additional FDA approval
Yahoo/AP
Monday, November 30, 2009 - 10:32am
tags:
FDA, generalized anxiety disorder, Cymbalta, Eli Lilly
Glaxo Sales Reps Are Denied Overtime By Court
Pharmalot
Monday, November 30, 2009 - 10:27am
tags:
GSK, drug reps, sales reps, overtime lawsuits
China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO
Seeking Alpha
Monday, November 30, 2009 - 10:25am
tags:
China, IPOs, Merck Serono, Pfizer, Gilead Sciences, GSK, Sinovac
Theravance says FDA wants more data before ruling on Vitabix for hospital-acquired pneumonia
Yahoo/AP
Monday, November 30, 2009 - 9:32am
tags:
Theravance, FDA, hospital infections, Vitabiv
13 Biotechs to Watch for at Hematology Conference
Seeking Alpha
Monday, November 30, 2009 - 9:30am
tags:
hematology, Allos, ONYX Pharmaceuticals, Facet Biotech, Seattle Genetics, Gentium, Immunogen, Cyclacel, Sunesis, Trubion, Pharmacyclics, Keryx, Aeterna Zentaris, Ariad Pharmaceuticals
Depomed Files Patent Infringement Lawsuit Against Lupin Limited
Yahoo
Monday, November 30, 2009 - 9:27am
tags:
Lupin, lawsuits, Depomed, Glumetza, patents
Turning the world of drugs upside down (GSK)
FT.com
Monday, November 30, 2009 - 9:27am
tags:
GSK
The fall of the world’s best-selling drug
FT.com
Monday, November 30, 2009 - 9:03am
tags:
Pfizer, Jeff Kindler, Lipitor
Novartis says FDA approves Agriflu seasonal shot
Yahoo/AP
Monday, November 30, 2009 - 9:01am
tags:
vaccines, Novartis, Flu, FDA, Agriflu
A Mostly Meaningless FDA Approval
Motley Fool
Friday, November 27, 2009 - 12:24pm
tags:
FDA, JNJ, Intelence, HIV
CytRx Announces First of Two Positive Developments Ahead
Seeking Alpha
Friday, November 27, 2009 - 11:23am
tags:
CytRx
Financing Drug Discovery: Recent Deals
Seeking Alpha
Friday, November 27, 2009 - 11:19am
tags:
Biogen Idec, drug discovery, Oxagen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.